Dr Karen Broder | Medical Officer
US Centers for Disease Control and Prevention

Dr Karen Broder, Medical Officer, US Centers for Disease Control and Prevention

Dr.  Karen R. Broder is the Team Lead for Clinical Immunization Safety Assessment (CISA) Project Team in the Centers for Disease Control and Prevention’s (CDC) Immunization Safety Office. The CISA Project is a collaboration between CDC, 7 medical research centers, and other federal partners. Dr. Broder’s team leads CDC’s effort to evaluate vaccine safety at the individual patient-level.  Since joining CDC in 2002, Dr. Broder’s work has spanned a wide spectrum of activities related to the US vaccination program, particularly in the areas of influenza and maternal vaccine safety.  Dr. Broder has conducted multiple studies and has contributed to several CDC public health responses, including the 2009 H1N1 pandemic, Ebola, and  Zika responses.  Dr. Broder has authored more than 125 scientific and public health articles and abstracts. She has received the United States Public Health Service outstanding service medal for contributions to vaccine safety and CDC group honor awards for contributions to the Zika and Ebola responses. Dr. Broder received a BA degree in biology from the University of Pennsylvania and an MD from Yale University School of Medicine. She completed her residency in pediatrics at Massachusetts General Hospital.  She completed CDC’s Epidemic Intelligence Service (EIS) Program in 2004.  She is currently board certified in pediatrics and volunteers as a primary care pediatrician at the Mercy Care clinic in the Atlanta area.


DC Co-conference Day 2 April 4 @ 4:40

CDC’s post-licensure vaccine safety monitoring systems – addressing 21st century public health needs

  • The Centers for Disease Control and Prevention (CDC) conducts post-licensure vaccine safety monitoring of licensed vaccines in U.S. children, adolescents and adults.
  • The three CDC post-licensure monitoring systems are the Vaccine Adverse Event Reporting System (VAERS), Vaccine Safety Datalink (VSD), and the Clinical Immunization Safety Assessment (CISA) Project. The functions of these systems complement each other and include passive surveillance (VAERS), active surveillance (VSD), clinical and epidemiologic research (VSD and CISA), and individual patient-level clinical case vaccine safety evaluations (CISA).
  • Overview of CDC’s post-licensure vaccine monitoring systems and describe some examples of how the systems have worked together to advance our understanding of vaccine safety.

back to speakers